News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,860 Results
Type
Article (59042)
Company Profile (161)
Press Release (637657)
Section
Business (195801)
Career Advice (2787)
Deals (35816)
Drug Delivery (104)
Drug Development (81308)
Employer Resources (161)
FDA (16570)
Job Trends (15236)
News (339665)
Policy (33690)
Tag
Academia (2757)
Alliances (49458)
Alzheimer's disease (1205)
Approvals (16480)
Artificial intelligence (123)
Bankruptcy (325)
Best Places to Work (11652)
Biosimilars (81)
Biotechnology (105)
Breast cancer (103)
Cancer (914)
Career advice (2356)
Cell therapy (213)
Clinical research (64194)
Collaboration (334)
Compensation (119)
COVID-19 (2615)
Cystic fibrosis (81)
Data (841)
Diabetes (134)
Diagnostics (6273)
Drug pricing (88)
Earnings (70964)
Employer resources (141)
Events (105528)
Executive appointments (252)
FDA (17011)
Funding (288)
Gene therapy (159)
GLP-1 (590)
Government (4741)
Healthcare (19189)
Infectious disease (2683)
Inflammatory bowel disease (107)
Interviews (527)
IPO (16276)
Job creations (3868)
Job search strategy (1991)
Layoffs (458)
Legal (7695)
Lung cancer (155)
Manufacturing (167)
Medical device (13667)
Medtech (13672)
Mergers & acquisitions (19574)
Metabolic disorders (356)
Neuroscience (1447)
NextGen Class of 2024 (6768)
Non-profit (4519)
Northern California (1147)
Obesity (210)
Opinion (224)
Patents (99)
People (59729)
Phase I (19984)
Phase II (28205)
Phase III (21007)
Pipeline (204)
Postmarket research (2592)
Preclinical (8549)
Radiopharmaceuticals (248)
Rare diseases (188)
Real estate (6513)
Regulatory (22493)
Research institute (2511)
Resumes & cover letters (418)
Southern California (1023)
Startups (3627)
United States (11132)
Vaccines (564)
Weight loss (167)
Date
Last 7 days (782)
Last 30 days (2725)
Last 365 days (35367)
2024 (29914)
2023 (39864)
2022 (51093)
2021 (55973)
2020 (54882)
2019 (48390)
2018 (36773)
2017 (33827)
2016 (33231)
2015 (39054)
2014 (31885)
2013 (28107)
2012 (29622)
2011 (29968)
2010 (28062)
Location
Africa (906)
Arizona (151)
Asia (41882)
Australia (7251)
California (2547)
Canada (1143)
China (209)
Colorado (111)
Connecticut (114)
Europe (94143)
Florida (379)
Georgia (102)
Illinois (333)
Indiana (171)
Kansas (98)
Maryland (517)
Massachusetts (2007)
Michigan (151)
Minnesota (230)
New Jersey (803)
New York (800)
North Carolina (698)
Northern California (1147)
Ohio (125)
Pennsylvania (691)
South America (1296)
Southern California (1023)
Texas (367)
Washington State (305)
696,860 Results for "wuhan institute of biological products".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
ADMA Biologics, Inc. announced Adam Grossman, President and Chief Executive Officer, will participate in a fireside chat at the Raymond James Institutional Investor Conference on March 6, 2024, at 11:35 a.m. ET.
March 5, 2024
·
2 min read
BIOSECURE Act
WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow
WuXi AppTec looks to unload its Philadelphia manufacturing sites and WuXi Biologics slows its rapid expansion in the U.S. as the companies await the Senate’s review of the BIOSECURE Act that threatens to cut them off from U.S. biopharma.
October 8, 2024
·
5 min read
·
Ben Hargreaves
Press Releases
Biological Safety Testing Products and Services Market to Hit $15.07 Bn by 2034
September 12, 2024
·
13 min read
News
Webinar: Revolutionizing Biologics Discovery: Harnessing the Power of AI and Patent Data
This webinar explores the pivotal role of patent data in overcoming the data challenges faced by generative AI models in drug discovery, particularly for biologics. Watch now.
October 23, 2024
·
1 min read
·
BioSpace Insights
Immutep successfully completes institutional placement and institutional component of entitlement offer
Immutep Limited ACN 009 237 889 is pleased to announce the successful completion of its institutional placement and the institutional component of its 1 for 16 pro rata accelerated non-renounceable entitlement offer of new fully paid ordinary shares in Immutep.
June 5, 2024
·
7 min read
Press Releases
Theriva Biologics Announces Orphan Medicinal Product Designation Granted by the European Commission to VCN-01 for the Treatment of Retinoblastoma
October 17, 2024
·
7 min read
Business
BioCina and NovaCina Forge Strategic Alliance to Offer Biologics Developers Integrated Drug Substance and Drug Product Solutions
BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation, and NovaCina Pty Ltd., a global fill-and-finish CDMO, announced a strategic partnership to provide integrated drug substance and drug product solutions for biologics developers.
February 27, 2024
·
3 min read
Press Releases
Boston Institute of Biotechnology & BiBo Pharma CEO Wins 2024 Global Biologics CDMO Technology Leadership Award
September 11, 2024
·
3 min read
Press Releases
Forge Biologics Announces the FUEL™ AAV Manufacturing Platform to Provide Developers with a More Efficient Solution for Gene Therapy Production
October 2, 2024
·
3 min read
Business
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
Dyadic International, Inc. announced it has advanced its collaboration with the Israel Institute for Biological Research (IIBR) and its commercial arm Life Science Research Israel.
February 21, 2024
·
5 min read
1 of 69,686
Next
